相关实验视频

Updated: Jun 3, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

GradeDiff-IM:一个集团基于模型的乳腺癌等级分类

Sweta Manna¹, Sujoy Mistry¹, Keshav Dahal²

¹Department of Computer Science & Engineering, Maulana Abul Kalam Azad University of Technology, West Bengal, India.

Biomedical physics & engineering express

|January 10, 2025

概括

本研究介绍了癌症分级的分级差异化综合模型 (GradeDiff-IM). 通过ML组合方法实现了比DL模型更高的准确性,改善了癌症分级的分类.

科学领域:

在瘤学瘤学.
计算生物学计算生物学
医疗成像医学成像

背景情况:

癌症等级分类对于治疗计划至关重要,因为它依赖于细胞结构分析.
深度学习 (DL) 模型被广泛使用,但在评分的特征选择中缺乏透明度.
现有的方法在癌症分级中扎着DL模型的解释性.

研究的目的:

提出一个可解释的模型,等级差异化综合模型 (GradeDiff-IM),用于分类癌症等级G1,G2和G3.
为了比较机器学习 (ML) 模型的性能与DL模型用于癌症等级分类.
为了提高分级分类的准确性,使用堆组装的ML方法.

主要方法:

利用临床和病理报告的ML模型进行等级分类.
采用了具有生物意义的特征与排名技术来优先考虑具有影响力的特征.
综合性基因病理图像用于DL模型的等级分类和比较.
实施了一个堆组合的方法,使用多个ML模型来提高性能.

主要成果:

堆组装的ML模型实现了高精度:G1 (98.2%),G2 (97.6%) 和G3 (97.5%).
拟议的ML组合模型与DL模型相比,显示出更高的准确性.
在癌症等级分类方面,GradeDiff-IM的表现优于其他最先进的模型.

结论:

机器学习组合方法,特别是堆叠,提供了比DL模型更高的准确性和可解释性,用于癌症分级.
GradeDiff-IM提供了一种强大而准确的方法来分类癌症等级G1,G2和G3.
该研究强调了在计算瘤学中整合ML,特征选择和组合技术的有效性.

关键词:

在这里,你会看到一个很棒的景点.在HER2中,HER2是HER2.在等级区分上,分级差异化.线粒细胞计数是指线粒细胞计数.核级核级核级核级核级核级核级管道形成的过程.

更多相关视频

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...